Ukrainian Children Cardiac Clinic, Chornovola str. 28/1, 1135 Kyiv, Ukraine.
Eur J Cardiothorac Surg. 2011 Oct;40(4):985-9. doi: 10.1016/j.ejcts.2011.01.011. Epub 2011 Feb 25.
This article describes the first clinical experience of complete repair of complex critical congenital heart diseases (CHDs) in the first hours of life using autologous umbilical cord blood (UCB). Prenatal diagnosis and harvesting of autologous UCB allow to modify perioperative management and to perform corrective surgery in the first hours of a patient's life. This approach can afford avoiding homologous blood transfusion and preventing development of hypoxemia and heart failure due to hemodynamic changes of complex critical CHD.
The study group included 14 consecutive prenatally diagnosed patients with critical complex CHD during the period from September 2009 to August 2010. Autologous UCB was harvested in accordance to NetCord-FACT International Standards for Cord Blood Collection and was used during the surgery with cardiopulmonary bypass (CPB). In all cases, complete repair was performed during the first hours of life: arterial switch operation (n=9); arterial switch operation with total anomalous pulmonary venous communication repair (n=1); arterial switch operation with interruption of the aortic arch repair (n=1); Ebstein's repair (n=2); and aortopulmonary window repair with interruption of the aortic arch repair (n=1). All procedures were performed using moderate hypothermia with cold-crystalloid cardioplegia, except one case that required deep hypothermic circulatory arrest.
A mean of 92±16 ml of UCB was harvested. Autologous UCB was used during the surgery in all 14 cases. Mean age of newborns at operation was 4.7±2 h (3-8). No patients required intensive care unit (ICU) admission, interventional procedures, mechanical ventilation, or medications before surgery. Twelve patients underwent bloodless open heart surgery; eight of them completely avoided homologous blood transfusion during the perioperative period. There was one postoperative death in our study (Ebstein's anomaly).
The use of autologous umbilical cord blood is feasible in neonatal open heart surgery. Complete surgical repair of complex critical CHD can be applied successfully to neonates within the first hours of life.
本文描述了首例在生命最初数小时内使用自体脐血(UCB)完全修复复杂危重先天性心脏病(CHD)的临床经验。产前诊断和自体 UCB 的采集可改变围手术期管理,并在患者生命的最初数小时内进行矫正手术。这种方法可以避免同源输血,并防止因复杂危重 CHD 的血液动力学变化而导致的低氧血症和心力衰竭。
研究组纳入了 2009 年 9 月至 2010 年 8 月期间产前诊断为危重复杂 CHD 的 14 例连续患者。根据 NetCord-FACT 脐带血采集国际标准采集自体 UCB,并在体外循环(CPB)期间用于手术。在所有情况下,均在生命最初数小时内完成完全修复:动脉调转术(n=9);动脉调转术合并完全性肺静脉异位引流修补术(n=1);动脉调转术合并主动脉弓中断修复术(n=1);Ebstein 畸形修复术(n=2);以及主动脉肺动脉窗修补术合并主动脉弓中断修复术(n=1)。除 1 例需要深低温停循环外,所有手术均采用中度低温冷晶体心脏停搏。
平均采集 92±16ml 的 UCB。14 例均在手术中使用自体 UCB。手术新生儿的平均年龄为 4.7±2 小时(3-8 小时)。术前无患者需要入住重症监护病房(ICU)、介入治疗、机械通气或药物治疗。12 例患者行无血开放心脏手术;其中 8 例在围手术期完全避免了同源输血。本研究中有 1 例术后死亡(Ebstein 畸形)。
自体脐血在新生儿心脏直视手术中是可行的。复杂危重 CHD 的完全手术修复可在生命最初数小时内成功应用于新生儿。